Literature DB >> 6734015

Amitriptyline dosage prediction in elderly patients from plasma concentration at 24 hours after a single 100mg dose.

S Dawling, S Ford, D C Rangedara, R R Lewis.   

Abstract

Fifteen depressed elderly patients (14 female, 1 male; mean age 85 years) received a single oral dose of amitriptyline. The concentration of amitriptyline plus nortriptyline in a blood sample taken 24 hours later was used to predict by means of a nomogram the amitriptyline dosage required for each patient. Each dose was selected to produce steady-state amitriptyline plus nortriptyline concentrations close to 140 micrograms/L. The daily dosage ranged from 20 to 100mg (mean 62mg). Patients received the individually calculated dose each night, and weekly blood samples were obtained for drug analysis. At 2 weeks, mean amitriptyline plus nortriptyline concentrations were 118 +/- 21 micrograms/L. Eight of the patients were studied for a further 2 weeks and the mean amitriptyline plus nortriptyline concentration was then 111 +/- 19 micrograms/L. The dose prediction test is easy to use and ensures each patient receives an adequate but safer dose of amitriptyline than might otherwise be prescribed routinely.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734015     DOI: 10.2165/00003088-198409030-00007

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  15 in total

1.  Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline.

Authors:  S Vandel; B Vandel; M Sandoz; G Allers; P Bechtel; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

2.  Radioimmunoassay for nortriptyline and amitriptyline.

Authors:  G W Aherne; V Marks; G Mould; G Stout
Journal:  Lancet       Date:  1977-06-04       Impact factor: 79.321

3.  Monitoring of tricyclic antidepressant therapy.

Authors:  S Dawling
Journal:  Clin Biochem       Date:  1982-02       Impact factor: 3.281

4.  Nortriptyline therapy in elderly patients: dosage prediction after single dose pharmacokinetic study.

Authors:  S Dawling; P Crome; R A Braithwaite; R R Lewis
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953

5.  Plasma levels, psychophysiological variables, and clinical response to amitriptyline.

Authors:  U Breyer-Pfaff; H J Gaertner; H Giedke
Journal:  Psychiatry Res       Date:  1982-04       Impact factor: 3.222

6.  Nortriptyline therapy in elderly patients: dosage prediction from plasma concentration at 24 hours after a single 50 mg dose.

Authors:  S Dawling; P Crome; E J Heyer; R R Lewis
Journal:  Br J Psychiatry       Date:  1981-11       Impact factor: 9.319

7.  Single-dose kinetics predict steady-state concentrations on imipramine and desipramine.

Authors:  W Z Potter; A P Zavadil; I J Kopin; F K Goodwin
Journal:  Arch Gen Psychiatry       Date:  1980-03

8.  Age and beta adrenoceptor-mediated function.

Authors:  N Dillon; S Chung; J Kelly; K O'Malley
Journal:  Clin Pharmacol Ther       Date:  1980-06       Impact factor: 6.875

9.  Factors influencing nortriptyline steady-state kinetics: plasma and saliva levels.

Authors:  P Kragh-Sørensen; N E Larsen
Journal:  Clin Pharmacol Ther       Date:  1980-12       Impact factor: 6.875

10.  Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose data.

Authors:  D J Brunswick; J D Amsterdam; J Mendels; S L Stern
Journal:  Clin Pharmacol Ther       Date:  1979-05       Impact factor: 6.875

View more
  3 in total

1.  Plasma concentrations of mianserin after single dose and at steady-state in depressed elderly patients.

Authors:  S Dawling; S Ford; P Ariyanayagam; H O'Neal; R R Lewis
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 2.  Discrepancies between pharmacokinetic studies of amitriptyline.

Authors:  P Schulz; P Dick; T F Blaschke; L Hollister
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

Review 3.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.